• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Research advances in genetic polymorphisms in Kawasaki disease].[川崎病基因多态性的研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1234-1238. doi: 10.7499/j.issn.1008-8830.2308073.
2
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease.全基因组关联研究确定了与川崎病冠状动脉瘤形成相关的新的易感基因。
PLoS One. 2016 May 12;11(5):e0154943. doi: 10.1371/journal.pone.0154943. eCollection 2016.
3
Immunogenetics of Kawasaki disease.川崎病的免疫遗传学。
Clin Rev Allergy Immunol. 2020 Aug;59(1):122-139. doi: 10.1007/s12016-020-08783-9.
4
Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.ADAM17的基因变异通过TGF-β/SMAD3信号通路参与川崎病及继发性冠状动脉病变的病理过程。
Eur J Pediatr. 2016 May;175(5):705-13. doi: 10.1007/s00431-016-2696-8. Epub 2016 Feb 1.
5
HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.HMGB1 基因多态性与川崎病冠状动脉病变及静脉注射免疫球蛋白抵抗相关。
Rheumatology (Oxford). 2019 May 1;58(5):770-775. doi: 10.1093/rheumatology/key356.
6
Identification of the TIFAB Gene as a Susceptibility Locus for Coronary Artery Aneurysm in Patients with Kawasaki Disease.鉴定TIFAB基因作为川崎病患者冠状动脉瘤的易感基因座。
Pediatr Cardiol. 2019 Mar;40(3):483-488. doi: 10.1007/s00246-018-1992-7. Epub 2018 Sep 28.
7
Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese.全基因组连锁易感位点分析在汉族人群川崎病中的作用。
Hum Genet. 2013 Jun;132(6):669-80. doi: 10.1007/s00439-013-1279-2. Epub 2013 Mar 1.
8
Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.针对川崎病易感基因的辅助草药疗法:川崎病的流行病学、发病机制、诊断及药物治疗概述
Phytomedicine. 2020 Apr 15;70:153208. doi: 10.1016/j.phymed.2020.153208. Epub 2020 Mar 18.
9
Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.台湾汉族人群中,PLCB4/PLCB1基因变异作为川崎病冠状动脉瘤形成的易感基因座
Sci Rep. 2015 Oct 5;5:14762. doi: 10.1038/srep14762.
10
The Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease.基因多态性 rs16944 和 rs1143627 增加了中国南方川崎病患儿冠状动脉损伤的风险。
J Immunol Res. 2019 Apr 9;2019:4730507. doi: 10.1155/2019/4730507. eCollection 2019.

引用本文的文献

1
Expression of Serum Ferritin, Human neutrophil lipocalin, Procalcitonin, and inflammatory factors in children with Kawasaki disease and their relationship to coronary artery lesions.血清铁蛋白、人中性粒细胞脂质运载蛋白、降钙素原及炎症因子在川崎病患儿中的表达及其与冠状动脉病变的关系
Am J Transl Res. 2025 Jan 15;17(1):286-293. doi: 10.62347/MIHQ2583. eCollection 2025.
2
Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.中国儿童不完全川崎病诊断与治疗指南。
BMC Pediatr. 2024 Jul 26;24(1):477. doi: 10.1186/s12887-024-04961-2.

本文引用的文献

1
Association of miR-181c/d gene locus rs8108402 C/T polymorphism with susceptibility to Kawasaki disease in Chinese children.miR-181c/d基因位点rs8108402 C/T多态性与中国儿童川崎病易感性的关联
Front Pediatr. 2022 Aug 9;10:899779. doi: 10.3389/fped.2022.899779. eCollection 2022.
2
PKC-Mediated Orai1 Channel Phosphorylation Modulates Ca Signaling in HeLa Cells.蛋白激酶 C 介导的 Orai1 通道磷酸化调节 HeLa 细胞中的钙信号转导。
Cells. 2022 Jun 27;11(13):2037. doi: 10.3390/cells11132037.
3
Association of SNP (rs1042579) in thrombomodulin gene and plasma thrombomodulin level in North Indian children with Kawasaki disease.血栓调节蛋白基因 SNP(rs1042579)与印度北部川崎病患儿血浆血栓调节蛋白水平的关系。
Mol Biol Rep. 2022 Aug;49(8):7399-7407. doi: 10.1007/s11033-022-07533-8. Epub 2022 May 19.
4
NFAT: platelet stickiness regulator.
Nat Rev Immunol. 2022 Feb;22(2):74-75. doi: 10.1038/s41577-022-00677-5.
5
Association of ITPKC gene polymorphisms rs28493229 and rs2290692 in North Indian children with Kawasaki disease.印度北部儿童川崎病与 ITPKC 基因多态性 rs28493229 和 rs2290692 的关联。
Pediatr Res. 2022 Oct;92(4):1090-1098. doi: 10.1038/s41390-021-01830-x. Epub 2021 Dec 24.
6
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.通过下一代测序技术鉴定川崎病中的循环 microRNA。
Curr Issues Mol Biol. 2021 Jun 25;43(2):485-500. doi: 10.3390/cimb43020037.
7
ORAI1 Ca Channel as a Therapeutic Target in Pathological Vascular Remodelling.ORAI1钙通道作为病理性血管重塑的治疗靶点
Front Cell Dev Biol. 2021 Apr 6;9:653812. doi: 10.3389/fcell.2021.653812. eCollection 2021.
8
The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis.γ干扰素(IFN-γ)和 IFN-γ 诱导蛋白 10(IP-10)基因多态性对丙型肝炎病毒相关肝硬化风险的影响。
Immunol Invest. 2022 Apr;51(3):688-704. doi: 10.1080/08820139.2020.1869251. Epub 2021 Jan 14.
9
Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19.观察性队列研究 IP-10 作为生物标志物在严重 COVID-19 患者临床决策支持方案中辅助炎症调节的潜力。
PLoS One. 2021 Jan 12;16(1):e0245296. doi: 10.1371/journal.pone.0245296. eCollection 2021.
10
Functional correlations between CXCL10/IP10 gene polymorphisms and risk of Kawasaki disease.CXCL10/IP10 基因多态性与川崎病风险的功能相关性。
Pediatr Allergy Immunol. 2021 Feb;32(2):363-370. doi: 10.1111/pai.13381. Epub 2020 Nov 6.

[川崎病基因多态性的研究进展]

[Research advances in genetic polymorphisms in Kawasaki disease].

作者信息

Dong Ming-Xing, Wang Xi-Xia, Jiao Fu-Yong, Zhang Wei-Hua

机构信息

Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712000, China/Xianyang Children's Hospital, Xianyang,Shaanxi 712000, China (Zhang W-H, Email: xiangyuelanda2006@126. com).

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1234-1238. doi: 10.7499/j.issn.1008-8830.2308073.

DOI:10.7499/j.issn.1008-8830.2308073
PMID:38112140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10731961/
Abstract

Kawasaki disease (KD) is a systemic inflammatory vascular disorder that predominantly affects children and is the leading cause of acquired heart disease in children. Although the etiology of this disease remains unclear, genome-wide association and genome-wide linkage studies have shown that some susceptible genes and chromosomal regions are associated with the development and progression of KD. With the advancement of high-throughput DNA sequencing techniques, more and more genomic information related to KD is being discovered. Understanding the genes involved in the pathogenesis of KD may provide novel insights into the diagnosis and treatment of KD. By analyzing related articles and summarizing related research advances, this article mainly discusses the T cell activation-enhancing genes that have been confirmed to be closely associated with the development and progression of KD and reveals their association with the pathogenesis of KD and coronary artery lesions.

摘要

川崎病(KD)是一种主要影响儿童的全身性炎症性血管疾病,是儿童后天性心脏病的主要原因。尽管该疾病的病因尚不清楚,但全基因组关联研究和全基因组连锁研究表明,一些易感基因和染色体区域与KD的发生和发展有关。随着高通量DNA测序技术的进步,越来越多与KD相关的基因组信息被发现。了解参与KD发病机制的基因可能为KD的诊断和治疗提供新的见解。通过分析相关文章并总结相关研究进展,本文主要讨论已被证实与KD的发生和发展密切相关的T细胞激活增强基因,并揭示它们与KD发病机制和冠状动脉病变的关联。